These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 25389805)

  • 21. Changes in levels of T cell subpopulations to monitor the response to antiretroviral therapy among HIV-1-infected patients during two years of HIV-1 replication suppression.
    Zhang JC; Zhang HJ; Li Y; Jing D; Liu Q; Zhao K; Liu QQ; Zhuang Y; Kang WZ; Sun YT
    Scand J Infect Dis; 2013 May; 45(5):368-77. PubMed ID: 23186319
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Initiation of Antiretroviral Therapy (ART) at Different Stages of HIV-1 Disease Is Not Associated with the Proportion of Exhausted CD8+ T Cells.
    Jensen SS; Fomsgaard A; Larsen TK; Tingstedt JL; Gerstoft J; Kronborg G; Pedersen C; Karlsson I
    PLoS One; 2015; 10(10):e0139573. PubMed ID: 26426913
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CCR5-edited CD4+ T cells augment HIV-specific immunity to enable post-rebound control of HIV replication.
    Tebas P; Jadlowsky JK; Shaw PA; Tian L; Esparza E; Brennan AL; Kim S; Naing SY; Richardson MW; Vogel AN; Maldini CR; Kong H; Liu X; Lacey SF; Bauer AM; Mampe F; Richman LP; Lee G; Ando D; Levine BL; Porter DL; Zhao Y; Siegel DL; Bar KJ; June CH; Riley JL
    J Clin Invest; 2021 Apr; 131(7):. PubMed ID: 33571163
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduced hepatitis B virus (HBV)-specific CD4+ T-cell responses in human immunodeficiency virus type 1-HBV-coinfected individuals receiving HBV-active antiretroviral therapy.
    Chang JJ; Wightman F; Bartholomeusz A; Ayres A; Kent SJ; Sasadeusz J; Lewin SR
    J Virol; 2005 Mar; 79(5):3038-51. PubMed ID: 15709024
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Profile of immunologic recovery in HIV-infected Ugandan adults after antiretroviral therapy.
    Baker CA; Emenyonu N; Ssewanyana I; Jones NG; Elrefaei M; Nghania F; Nakiwala J; Andia I; Clark R; Martin J; Bangsberg DR; Cao H
    AIDS Res Hum Retroviruses; 2007 Jul; 23(7):900-5. PubMed ID: 17678474
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dynamics of the HIV-1 latent reservoir after discontinuation of the intensification of antiretroviral treatment: results of two clinical trials.
    Gutiérrez C; Hernández-Novoa B; Vallejo A; Serrano-Villar S; Abad-Fernández M; Madrid N; Díaz L; Moreno A; Dronda F; Zamora J; Muñoz-Fernández MA; Moreno S
    AIDS; 2013 Aug; 27(13):2081-8. PubMed ID: 24384589
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Establishment and Replenishment of the Viral Reservoir in Perinatally HIV-1-infected Children Initiating Very Early Antiretroviral Therapy.
    Martínez-Bonet M; Puertas MC; Fortuny C; Ouchi D; Mellado MJ; Rojo P; Noguera-Julian A; Muñoz-Fernández MA; Martinez-Picado J
    Clin Infect Dis; 2015 Oct; 61(7):1169-78. PubMed ID: 26063721
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Broadly neutralizing antibody and the HIV reservoir in acute HIV infection: a strategy toward HIV remission?
    Ananworanich J; McSteen B; Robb ML
    Curr Opin HIV AIDS; 2015 May; 10(3):198-206. PubMed ID: 25700203
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of antiretroviral therapy (ART) timing on chronic immune activation/inflammation and end-organ damage.
    Rajasuriar R; Wright E; Lewin SR
    Curr Opin HIV AIDS; 2015 Jan; 10(1):35-42. PubMed ID: 25415420
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunization with an HIV-1 immunogen induces CD4+ and CD8+ HIV-1-specific polyfunctional responses in patients with chronic HIV-1 infection receiving antiretroviral therapy.
    Valor L; Navarro J; Carbone J; Rodríguez-Sáinz C; Gil J; López F; Fernández-Cruz E;
    Vaccine; 2008 May; 26(22):2738-45. PubMed ID: 18433946
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of antiretroviral therapy and changes in virus load on human immunodeficiency virus (HIV)-specific T cell responses in primary HIV infection.
    Lacabaratz-Porret C; Urrutia A; Doisne JM; Goujard C; Deveau C; Dalod M; Meyer L; Rouzioux C; Delfraissy JF; Venet A; Sinet M
    J Infect Dis; 2003 Mar; 187(5):748-57. PubMed ID: 12599048
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immune activation during acute HIV infection and the impact of early antiretroviral therapy.
    Krebs SJ; Ananworanich J
    Curr Opin HIV AIDS; 2016 Mar; 11(2):163-72. PubMed ID: 26599167
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Normalization of CD4+ cell numbers and reduced levels of memory CD8+ cells in blood and tonsillar tissue after highly active antiretroviral therapy in early HIV type-1 infection.
    Dyrhol-Riise AM; Voltersvik P; Røsok BI; Olofsson J; Asjö B
    AIDS Res Hum Retroviruses; 2000 Feb; 16(3):191-201. PubMed ID: 10710207
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intradermal vaccination of HIV-infected patients with short HIV Gag p24-like peptides induces CD4 + and CD8 + T cell responses lasting more than seven years.
    Lind A; Sommerfelt M; Holmberg JO; Baksaas I; Sørensen B; Kvale D
    Scand J Infect Dis; 2012 Aug; 44(8):566-72. PubMed ID: 22339485
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CD38 expression on CD8 T cells has a weak association with CD4 T-cell recovery and is a poor marker of viral replication in HIV-1-infected patients on antiretroviral therapy.
    Steel A; John L; Shamji MH; Henderson DC; Gotch FM; Gazzard BG; Kelleher P
    HIV Med; 2008 Feb; 9(2):118-25. PubMed ID: 18257774
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Close association of CD8+/CD38 bright with HIV-1 replication and complex relationship with CD4+ T-cell count.
    Tuaillon E; Al Tabaa Y; Baillat V; Segondy M; Picot MC; Reynes J; Vendrell JP
    Cytometry B Clin Cytom; 2009 Jul; 76(4):249-60. PubMed ID: 19072838
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Presence of human immunodeficiency virus-1-specific CD4 and CD8 cellular immune responses in children with full or partial virus suppression.
    Papasavvas E; Sandberg JK; Rutstein R; Moore EC; Mackiewicz A; Thiel B; Pistilli M; June RR; Jordan KA; Gross R; Maino VC; Nixon DF; Montaner LJ
    J Infect Dis; 2003 Sep; 188(6):873-82. PubMed ID: 12964119
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Short communication: HIV antigen-specific reactivation of HIV infection from cellular reservoirs: implications in the settings of therapeutic vaccinations.
    Shete A; Thakar M; Singh DP; Gangakhedkar R; Gaikwad A; Pawar J; Paranjape R
    AIDS Res Hum Retroviruses; 2012 Aug; 28(8):835-43. PubMed ID: 21936714
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of earlier combination antiretroviral therapy on outcomes in children.
    Cotton MF; Rabie H
    Curr Opin HIV AIDS; 2015 Jan; 10(1):12-7. PubMed ID: 25389804
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Review: Influence of ART on HIV genetics.
    Simonetti FR; Kearney MF
    Curr Opin HIV AIDS; 2015 Jan; 10(1):49-54. PubMed ID: 25389802
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.